DRL-Header DRL-Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter
×
FILTER:
filter News Type
    filter Company
      filter Product Type
        filter Deal Size
          filter Upfront Payment

            Active Filter(s):

            Product Type

            Companies

            Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE

            Lead Product(s): WP1122

            Therapeutic Area: Infections and Infectious Diseases Product Name: WP1122

            Highest Development Status: Preclinical Product Type: Small molecule

            Partner/Sponsor/Collaborator: Dermin

            Deal Size: Undisclosed Upfront Cash: Undisclosed

            Deal Type: Collaboration August 17, 2020

            Details:

            Under the collaborative agreement, WPD is not required to pay Dermin or grant a royalty for the rights transferred, but is required to provide Dermin with all its research data, if any, which Dermin may use for the further development of WP1122 as an anti-glioma drug.